The Cigna Group announces president & COO Brian Evanko to succeed David Cordani as CEO
Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group board of directors.
Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group board of directors.
Mark Davis joins as vice president of Health Plans & Strategic Growth and Steve Halleen enters as senior director of Consultant Relations.
The Amaya Edit showcases the newest ambassador's hand-picked favorite styles from the NEW. MORE. BETTER
Organizations that align pricing logic, rebate governance, and financial controls directly within workflow execution are better positioned to create rule-driven claim outcomes and maintain audit-ready records without relying on retrospective reconciliation.
Fourth-quarter net sales declined 1.5% to $30.5 billion, while comparable sales fell 2.5%
Limited-edition McCormick Harry Potter Butterbeer Finishing Sugar and Flavor are available now at Walmart, Amazon, and retailers nationwide
Expanded collaboration establishes Guiding Stars as PHA’s nutrition standard and marks new phase of partnership.
NIQ and Kearney analysis finds challenger brands gaining share as AI reshapes innovation and product discovery
Pros Akshay Bhatia and Neal Shipley will work with the brand to highlight how allergy relief helps them feel their best on the course.
Jerry LeClair will assume the role of interim CEO.
CVS would have to close or sell its outlets in Nashville, and the rest of Tennessee, if state legislation barring ownership of pharmacies by PBMs becomes state law.
The era of agentic commerce gets underway.
An elevated, refreshingly tangy limited-time swirl arriving at Menchie's locations nationwide.
Multi-media blitz emphasizes how big chain drugstores and mail-order operations treat customers like a number rather than a neighbor.
KNAPP empowers businesses to master value chain complexity.
This year, a combination of rising pharmacy costs and increased regulatory risk has led to a tipping point for the PBM industry.